Every Form 4 that Leverage Shares 2X Long FIX Daily ETF (FIXX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow FIXX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FIXX filings page.
Q32 Bio Inc. (FIXX) director and CEO Jodie Pope Morrison reported a sale of 9,845 shares of common stock on August 25, 2026, at $16.56 per share. According to the disclosure, the shares were sold automatically to cover tax withholding obligations arising from vesting restricted stock units, not at the reporting person’s discretion. Following this transaction, Morrison directly holds 343,259 shares of Q32 Bio common stock.
Q32 Bio Inc. (FIXX) reported that officer Lee Kalowski, CFO and President, had 3,972 shares of common stock sold on 2026-08-25 at $16.56 per share. A footnote states these shares were sold automatically to cover tax withholding obligations on vesting RSUs, not at the officer’s discretion. Following this transaction, Kalowski directly holds 138,471 shares of Q32 Bio common stock.
Q32 Bio Inc. (FIXX) reported that Chief Scientific Officer Shelia M. Violette had an automatic sale of 2,798 shares of common stock on 2026-08-25 at $16.56 per share. The shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units and were not sold at her discretion. Following this transaction, she holds 127,771 shares directly and has 36,277 shares reported as indirectly held through Violette Holdings LLC, for which she disclaims beneficial ownership except to the extent of any pecuniary interest.